AB817,59,119
961.18
(3) (m) (intro.) Any compound, mixture, or preparation containing
10amobarbital, secobarbital, pentobarbital any of the following drugs and one or more
11other active medicinal ingredients
which are not
listed included in any schedule
.
:
AB817, s. 196
12Section
196. 161.18 (3) (n) of the statutes is renumbered 961.18 (3) (n) (intro.)
13and amended to read:
AB817,59,1614
961.18
(3) (n) (intro.) Any
of the following drugs in suppository dosage form
15containing amobarbital, secobarbital or pentobarbital and approved by the federal
16food and drug administration for marketing only as a suppository
.:
AB817, s. 197
17Section
197. 161.18 (4) of the statutes is renumbered 961.18 (4), and 961.18
18(4) (intro.), as renumbered, is amended to read:
AB817,59,2419
961.18
(4) Other substances. (intro.)
Unless specifically excepted under
20federal regulations or unless listed in another schedule, any
Any material,
21compound, mixture or preparation which contains any quantity of the following
22substances
or, including any of their salts, isomers
or and salts of isomers
, if salts,
23isomers or salts of isomers exist under that are theoretically possible within the
24specific chemical designation:
AB817, s. 198
1Section
198. 161.18 (5) of the statutes is renumbered 961.18 (5), and 961.18
2(5) (intro.), (a), (b), (c), (d), (e) and (f), as renumbered, are amended to read:
AB817,60,73
961.18
(5) Narcotic drugs. (intro.)
Unless specifically excepted under federal
4regulations or unless listed in another schedule, any Any material, compound,
5mixture or preparation containing any of the following narcotic drugs or their salts,
6isomers or salts of isomers, calculated as the free anhydrous base or alkaloid, in
the
7following specified limited quantities
as follows:
AB817,60,108
(a) Not more than 1.8 grams of codeine per 100 milliliters
or per 100 grams or
9not more than 90 milligrams per dosage unit, with an equal or greater quantity of
10an isoquinoline alkaloid of opium
;.
AB817,60,1311
(b) Not more than 1.8 grams of codeine per 100 milliliters
or per 100 grams or
12not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic
13ingredients in recognized therapeutic amounts
;.
AB817,60,1614
(c) Not more than 300 milligrams of hydrocodone per 100 milliliters
or per 100
15grams or not more than 15 milligrams per dosage unit, with a four-fold or greater
16quantity of an isoquinoline alkaloid of opium
;.
AB817,60,1917
(d) Not more than 300 milligrams of hydrocodone per 100 milliliters
or per 100
18grams or not more than 15 milligrams per dosage unit, with one or more active,
19nonnarcotic ingredients in recognized therapeutic amounts
;
.
AB817,60,2220
(e) Not more than 1.8 grams of dihydrocodeine per 100 milliliters
or per 100
21grams or not more than 90 milligrams per dosage unit, with one or more active,
22nonnarcotic ingredients in recognized therapeutic amounts
;
.
AB817,60,2523
(f) Not more than 300 milligrams of ethylmorphine per 100 milliliters
or per
24100 grams or not more than 15 milligrams per dosage unit, with one or more
25ingredients in recognized therapeutic amounts
;.
AB817, s. 199
1Section
199. 161.18 (6) of the statutes is renumbered 961.18 (6) and amended
2to read:
AB817,61,113
961.18
(6) Exceptions. The controlled substances board may except by rule any
4compound, mixture or preparation containing any stimulant or depressant
5substance
listed included in sub.
(2m) or (3) from the application of all or any part
6of this chapter if the compound, mixture or preparation contains one or more active
7medicinal ingredients not having a stimulant or depressant effect on the central
8nervous system, and if the admixtures are included therein in combinations,
9quantity, proportion or concentration that vitiate the potential for abuse of the
10substances which have a stimulant or depressant effect on the central nervous
11system.
AB817, s. 200
12Section
200. 161.18 (7) of the statutes is renumbered 961.18 (7), and 961.18
13(7) (intro.), as renumbered, is amended to read:
AB817,61,1914
961.18
(7) (title)
Anabolic Steroids steroids. (intro.) Any material,
15compound, mixture, or preparation containing any quantity of
any of the following
16anabolic steroids, including any of their esters, isomers, esters of isomers, salts and
17salts of esters, isomers and esters of isomers
, whenever those esters, isomers, esters
18of isomers, salts and salts, esters, isomers and esters of isomers exist that are
19theoretically possible within the specific chemical designation:
AB817, s. 201
20Section
201. 161.19 (title) of the statutes is renumbered 961.19 (title).
AB817, s. 202
21Section
202. 161.19 of the statutes is renumbered 961.19 (1m), and 961.19
22(1m) (intro.), (a) and (c), as renumbered, are amended to read:
AB817,61,2423
961.19
(1m) (intro.) The controlled substances board shall
place add a
24substance
in to schedule IV
if it finds upon finding that:
AB817,62,2
1(a) The substance has a low potential for abuse relative to substances
included 2in schedule III;
AB817,62,43
(c) Abuse of the substance may lead to limited physical dependence or
4psychological dependence relative to the substances
included in schedule III.
AB817, s. 203
5Section
203. 161.20 (title) of the statutes is renumbered 961.20 (title).
AB817, s. 204
6Section
204. 161.20 (1) (title) of the statutes is repealed.
AB817, s. 205
7Section
205. 161.20 (1) of the statutes is renumbered 961.20 (intro.) and
8amended to read:
AB817,62,119
961.20 (intro.)
The Unless specifically excepted by state or federal law or
10regulation or more specifically included in another schedule, the following controlled
11substances
are listed in
this section are included in schedule IV
.:
AB817, s. 206
12Section
206. 161.20 (2) of the statutes is renumbered 961.20 (2), and 961.20
13(2) (intro.) and (h), as renumbered, are amended to read:
AB817,62,1914
961.20
(2) Depressants. (intro.)
Unless specifically excepted under federal
15regulations or unless listed in another schedule, any Any material, compound,
16mixture or preparation which contains any quantity of
any of the following
17substances having a depressant effect on the central nervous system
or, including
18any of their salts, isomers
or and salts of isomers
, if salts, isomers or salts of isomers
19exist under that are theoretically possible within the specific chemical designation:
AB817,62,2020
(h) Methylphenobarbital
, which is also called mephobarbital;
AB817, s. 207
21Section
207. 161.20 (2m) (intro.) of the statutes is renumbered 961.20 (2m)
22(intro.) and amended to read:
AB817,63,323
961.20
(2m) Stimulants. (intro.)
Unless specifically excepted under federal
24regulations or unless listed in another schedule, any Any material, compound,
25mixture, or preparation which contains any quantity of
any of the following
1substances having a stimulant effect on the central nervous system
or, including any
2of their salts, isomers
or and salts of isomers
, if salts, isomers or salts of isomers exist
3under that are theoretically possible within the specific chemical designation:
AB817, s. 208
4Section
208. 161.20 (2m) (a) of the statutes is renumbered 961.20 (2m) (a).
AB817, s. 209
5Section
209. 161.20 (2m) (ag) of the statutes is renumbered 961.20 (2m) (ag)
6and amended to read:
AB817,63,87
961.20
(2m) (ag)
N,N-dimethyl-1-1,2-diphenylethylamine 8N,N-dimethyl-1,2-diphenylethylamine, commonly known as "SPA"
;.
AB817, s. 210
9Section
210. 161.20 (2m) (ar) of the statutes is renumbered 961.20 (2m) (ar)
10and amended to read:
AB817,63,1111
961.20
(2m) (ar) Fencamfamine
;.
AB817, s. 211
12Section
211. 161.20 (2m) (b) of the statutes is renumbered 961.20 (4) (am) and
13amended to read:
AB817,63,1414
961.20
(4) (am) Fenfluramine
, including any of its isomers and salts of isomers.
AB817, s. 212
15Section
212. 161.20 (2m) (bm) of the statutes is renumbered 961.20 (2m) (bm)
16and amended to read:
AB817,63,1717
961.20
(2m) (bm) Mazindol
;.
AB817, s. 213
18Section
213. 161.20 (2m) (c) of the statutes is renumbered 961.20 (2m) (c) and
19amended to read:
AB817,63,2020
961.20
(2m) (c) Pemoline
, including its organometallic complexes and chelates.
AB817, s. 214
21Section
214. 161.20 (2m) (d) of the statutes is renumbered 961.20 (2m) (d).
AB817, s. 215
22Section
215. 161.20 (2m) (e) of the statutes is renumbered 961.20 (2m) (e).
AB817, s. 216
23Section
216. 161.20 (3) of the statutes is renumbered 961.20 (3), and 961.20
24(3) (intro.), as renumbered, is amended to read:
AB817,64,8
1961.20
(3) Narcotic drugs containing nonnarcotic active medicinal
2ingredients. (intro.) Any compound, mixture or preparation containing
limited
3quantities of any of the following narcotic drugs or their salts, isomers or salts of
4isomers,
in limited quantities as set forth below, calculated as the free anhydrous
5base or alkaloid, which also contains one or more nonnarcotic, active medicinal
6ingredients in sufficient proportion to confer upon the compound, mixture or
7preparation valuable medicinal qualities other than those possessed by the narcotic
8drug alone:
AB817, s. 217
9Section
217. 161.20 (3m) (title) of the statutes is repealed.
AB817, s. 218
10Section
218. 161.20 (3m) of the statutes is renumbered 961.20 (2m) (ak) and
11amended to read:
AB817,64,1812
961.20
(2m) (ak)
Unless specifically excepted under federal regulations or
13unless listed in another schedule, any material, compound, mixture or preparation
14that contains any quantity of ephedrine or a salt of ephedrine, an optical isomer of
15ephedrine or a salt of an optical isomer of ephedrine. This subsection applies only 16Ephedrine, if
the ephedrine
, salt, optical isomer or salt of the optical isomer is the
17only active medicinal ingredient or if there are only therapeutically insignificant
18quantities of another active medicinal ingredient.
AB817, s. 219
19Section
219. 161.20 (4) of the statutes is renumbered 961.20 (4), and 961.20
20(4) (intro.) and (b), as renumbered, are amended to read:
AB817,64,2421
961.20
(4) Other substances. (intro.)
Unless specifically excepted under
22federal regulations or unless listed in another schedule, any
Any material,
23compound, mixture or preparation which contains any quantity of
any of the
24following substances or their salts:
AB817,64,2525
(b) Pentazocine, including
any of its isomers and salts of isomers.
AB817, s. 220
1Section
220. 161.20 (5) of the statutes is renumbered 961.20 (5) and amended
2to read:
AB817,65,103
961.20
(5) Exceptions. The controlled substances board may except by rule any
4compound, mixture or preparation containing any depressant substance
listed 5included in sub. (2) from the application of all or any part of this chapter if the
6compound, mixture or preparation contains one or more active medicinal ingredients
7not having a depressant effect on the central nervous system, and if the admixtures
8are
included therein in combinations, quantity, proportion or concentration that
9vitiate the potential for abuse of the substances which have a depressant effect on
10the central nervous system.
AB817, s. 221
11Section
221. 161.21 (title) of the statutes is renumbered 961.21 (title).
AB817, s. 222
12Section
222. 161.21 of the statutes is renumbered 961.21 (1m), and 961.21
13(1m) (intro.), (a) and (c), as renumbered, are amended to read:
AB817,65,1514
961.21
(1m) (intro.) The controlled substances board shall
place add a
15substance
in to schedule V
if it finds upon finding that:
AB817,65,1716
(a) The substance has low potential for abuse relative to the controlled
17substances
listed included in schedule IV;
AB817,65,2018
(c) The substance has limited physical dependence or psychological
19dependence liability relative to the controlled substances
listed included in schedule
20IV.
AB817, s. 223
21Section
223. 161.22 (title) of the statutes is renumbered 961.22 (title).
AB817, s. 224
22Section
224. 161.22 (1) (title) of the statutes is repealed.
AB817, s. 225
23Section
225. 161.22 (1) of the statutes is renumbered 961.22 (intro.) and
24amended to read:
AB817,66,3
1961.22 (intro.)
The Unless specifically excepted by state or federal law or
2regulation or more specifically included in another schedule, the following controlled
3substances
are listed in
this section are included in schedule V
.:
AB817, s. 226
4Section
226. 161.22 (1m) of the statutes is renumbered 961.22 (1m), and
5961.22 (1m) (intro.), as renumbered, is amended to read:
AB817,66,116
961.22
(1m) Narcotic drugs. (intro.)
Unless specifically excepted under
7federal regulations or unless listed in another schedule, Any material, compound,
8mixture or preparation containing any quantity of
any of the following substances
9or, including any of their salts, isomers
or and salts of isomers
, if salts, isomers or
10salts of isomers exist under that are theoretically possible within the specific
11chemical designation
.:
AB817, s. 227
12Section
227. 161.22 (2) of the statutes is renumbered 961.22 (2), and 961.22
13(2) (intro.), as renumbered, is amended to read:
AB817,66,2114
961.22
(2) Narcotic drugs containing nonnarcotic active medicinal
15ingredients. (intro.) Any compound, mixture or preparation containing
limited
16quantities of any of the following narcotic drugs or their salts, isomers or salts of
17isomers,
in limited quantities as set forth below, calculated as the free anhydrous
18base or alkaloid, which also contains one or more nonnarcotic, active medicinal
19ingredients in sufficient proportion to confer upon the compound, mixture or
20preparation, valuable medicinal qualities other than those possessed by the narcotic
21drug alone:
AB817, s. 228
22Section
228. 161.23 of the statutes is renumbered 961.23, and 961.23 (4), as
23renumbered, is amended to read:
AB817,67,424
961.23
(4) That any person purchasing such a substance at the time of purchase
25present to the seller that person's correct name and address. The seller shall record
1the name and address and the name and quantity of the product sold. The purchaser
2and the seller shall sign the record of this transaction. The giving of a false name or
3false address by the purchaser shall be prima facie evidence of a violation of s.
161.43 4961.43 (1) (a).
AB817, s. 229
5Section
229. 161.24 of the statutes is renumbered 961.24 and amended to
6read:
AB817,67,11
7961.24 (title)
Republishing
Publishing of updated schedules. The
8controlled substances board shall
revise and republish the publish updated 9schedules annually.
The failure of the controlled substances board to publish an
10updated schedule under this section is not a defense in any administrative or judicial
11proceeding under this chapter.
AB817, s. 230
12Section
230. Subchapter III (title) of chapter 161 [precedes 161.31] of the
13statutes is renumbered subchapter III (title) of chapter 961 [precedes 961.31].
AB817, s. 231
14Section
231. 161.31 of the statutes is renumbered 961.31.
AB817, s. 232
15Section
232. 161.32 of the statutes is renumbered 961.32.
AB817, s. 233
16Section
233. 161.335 of the statutes is renumbered 961.335, and 961.335 (4)
17(c), as renumbered, is amended to read:
AB817,67,1918
961.335
(4) (c) The controlled substances to be used in the project, by name if
19included in schedule I, and by name or schedule if
included in any other schedule.
AB817, s. 234
20Section
234. 161.36 of the statutes is renumbered 961.36 and amended to
21read:
AB817,68,2
22961.36 Diversion control and prevention. (1) The controlled substances
23board shall regularly prepare and make available to state regulatory, licensing and
24law enforcement agencies descriptive and analytic reports on the potential for
25diversion and actual
diversion patterns
and trends of distribution, diversion and
1abuse within the state of certain controlled substances the board selects that are
2listed in s.
161.16, 161.18, 161.20 or 161.22 961.16, 961.18, 961.20 or 961.22.
AB817,68,14
3(2) The controlled substances board shall enter into written agreements with
4other local, state
or and federal agencies to
improve the identification of sources of
5diversion and to improve enforcement of and compliance with this chapter and other
6laws and regulations pertaining to unlawful conduct involving controlled
7substances. An agreement must specify the roles and responsibilities of each agency
8that has information or authority to identify, prevent or control drug diversion and
9drug abuse. The board shall convene periodic meetings to coordinate a state
10diversion prevention and control program. The board shall assist and promote
11coordination of cooperation and exchange of information among agencies
responsible
12for ensuring compliance with controlled substances law, to monitor observance of
13these laws and to monitor cooperation between the agencies and with other states
14and the federal government.
AB817,68,20
15(3) The controlled substances board shall evaluate the outcome of its program
16under this section and shall annually submit a report to the chief clerk of each house
17of the legislature, for distribution
to the legislature under s. 13.172 (3), on its findings
18with respect to its effect on distribution and
abuse of controlled substances, including 19recommendations for improving control and prevention of the diversion of controlled
20substances.
AB817, s. 235
21Section
235. 161.38 (title) of the statutes is renumbered 961.38 (title).
AB817, s. 236
22Section
236. 161.38 (1) of the statutes is renumbered 961.38 (1r) and amended
23to read:
AB817,69,3
1961.38
(1r) Except when dispensed directly by a practitioner, other than a
2pharmacy, to an ultimate user, no controlled substance
included in schedule II may
3be dispensed without the written prescription of a practitioner.
AB817, s. 237
4Section
237. 161.38 (2) of the statutes is renumbered 961.38 (2) and amended
5to read:
AB817,69,116
961.38
(2) In emergency situations, as defined by rule of the pharmacy
7examining board, schedule II drugs may be dispensed upon oral prescription of a
8practitioner, reduced promptly to writing and filed by the pharmacy. Prescriptions
9shall be retained in conformity with rules of the pharmacy examining board
10promulgated under s.
161.31 961.31. No prescription for a schedule II substance may
11be refilled.
AB817, s. 238
12Section
238. 161.38 (3) of the statutes is renumbered 961.38 (3).
AB817, s. 239
13Section
239. 161.38 (4) of the statutes is renumbered 961.38 (4) and amended
14to read:
AB817,69,1715
961.38
(4) A
controlled substance included in schedule V
shall not may be
16distributed or dispensed
other than only for a medical purpose
, including medical
17treatment or authorized research.
AB817, s. 240
18Section
240. 161.38 (5) of the statutes is renumbered 961.38 (5).